INOD vs TU: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: TU is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. INOD and TU share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined INOD and TU exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Innodata is a data-engineering and AI-services company that provides the training data, data annotation, fine-tuning, evaluation, and safety or red-teaming work that organizations use to build and improve AI systems. Its customers include several of the largest technology companies, often described as building frontier generative-AI models, and Innodata positions itself less as a one-off data supplier and more as a lifecycle partner across model training, agentic AI, and emerging physical-AI workloads. The work blends software platforms with large pools of human expertise.

Full INOD guide

TELUS Corporation is a Vancouver-based communications technology company with roughly 100,000 team members and operations in more than 45 countries. Its core is TELUS Technology Solutions (TTech), the Canadian connectivity business, which ended the second quarter of 2026 with about 17.9 million customer connections: roughly 10.3 million mobile phone subscribers, ~2.8 million internet subscribers and ~4.8 million connected devices, on a 5G network reaching about 34.2 million Canadians (over 92% of the population) alongside the TELUS PureFibre footprint. TELUS Health administers employer benefits, virtual care, electronic medical records and pharmacy solutions for approximately 158.9 million covered lives across about 200 countries and territories. TELUS Digital, formerly the separately listed TELUS International and since taken fully private by the parent, does outsourced customer experience work and AI data annotation. Revenue runs at roughly C$20.2 billion on a trailing twelve month basis, reported in Canadian dollars under IFRS, with SEC filings made as a Canadian foreign private issuer on Form 40-F.

Full TU guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• INOD drivers: Riding AI-data demand; Expanding the big-tech roster.
• TU drivers: Deleveraging is now the stated first priority; Pricing discipline against slower population growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Customer concentration is the headline risk: a single customer has recently accounted for a majority of revenue and a second for a large slice, so losing or shrinking one relationship could hit results hard. For TU, leverage dominates: total debt of roughly $22.2 billion against about $984 million of cash (US dollar basis) leaves little room if adjusted EBITDA falls faster than guided, and the 2028 deleveraging target already represents one slip from the prior 2027 date.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick INOD if you believe its drivers more; TU if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the INOD and TU guides.

INOD. Figures are approximate and tied to the asOf date; verify current numbers before acting. Innodata has grown revenue rapidly while turning profitable, but it trades at a high multiple of earnings and sales (roughly a high-single to low-double-digit price-to-sales and a P/E in the mid-60s trailing, higher on forward estimates). A premium valuation means the market is pricing in continued fast growth, so results that merely meet expectations may not move the stock the way the headline growth rate suggests.

TU. TELUS reports in Canadian dollars, so the operating figures above are CAD while market capitalization and enterprise value are the US dollar values behind the NYSE quote. Trailing earnings are negative because of the second quarter impairment, which is why a trailing P/E is unavailable and screeners show a forward multiple near ~18.8x instead. On enterprise value the shares change hands around ~10.9 times trailing EBITDA and ~1.1 times sales.

Headline figures (approximate, 2026-06-27): INOD shows revenue (fy2025) ~$251.7M, revenue growth (fy2025 yoy) ~48%, q1 2026 revenue / growth ~$90.1M, ~54% YoY, adjusted gross margin (recent) ~47%; TU shows revenue (ttm, as reported) ~C$20.2 billion, q2 2026 net loss (incl. ~c$2.1b non-cash impairment) ~C$1.8 billion, free cash flow (2026 company guidance, revised) ~C$1.8 billion, net debt to adjusted ebitda (q2 2026) ~3.5 times.

INOD and TU are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined INOD and TU exposure against your real portfolio. It is not an investment adviser.